feed,title,long_url,short_url
Investors,Gilead Dives As HHS Reportedly Mulls Cutting HIV Prevention Funding,https://www.investors.com/news/technology/gilead-stock-hiv-prevention-funding/,https://da.gd/baujLk
Investors,Roivant And Immunovant Won't Seek Approval Despite Phase 3 Win. Why Shares Rallied.,https://www.investors.com/news/technology/roivant-sciences-immunovant-batoclimab-imvt-1402/,https://da.gd/3JKBo
Investors,Nvidia Stock Up As Tech Giant Widens Competitive Moat With AI Advances,https://www.investors.com/news/technology/nvidia-stock-wall-street-analysts-react-to-gtc-news/,https://da.gd/fFVue
